Sands Capital Management 13F holdings, Q4 2008
Holdings as of December 31, 2008 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 36 US equity positions worth $6.2bn in its Q4 2008 13F filing. The largest position was GENZYME CORP at 8.9% of the reported book, followed by AAPL and ALLERGAN INC. Against the Q3 2008 filing, it opened 6 new positions, added to 8 and reduced 22 among the top 36 holdings.
What did Sands Capital Management own in Q4 2008? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2008 |
|---|---|---|---|---|---|---|---|
| 1 | GENZYME CORP | 8.9% | $550.8m | 8,299,112 | -22% | reduced | |
| 2 | AAPL APPLE INC | Technology | 8.3% | $514.3m | 6,025,572 | -2% | reduced |
| 3 | ALLERGAN INC | 8.2% | $511.3m | 12,680,439 | -12% | reduced | |
| 4 | INTERCONTINENTALEXCHANGE INC | 8.1% | $505.3m | 6,128,711 | -3% | reduced | |
| 5 | NATIONAL OILWELL VARCO INC | 7.1% | $443.9m | 18,163,469 | 15% | added | |
| 6 | V VISA INC | Financial Services | 7.1% | $441.6m | 8,419,255 | -2% | reduced |
| 7 | SLB SCHLUMBERGER LTD | Energy | 6.1% | $377.5m | 8,918,127 | -8% | reduced |
| 8 | CRM SALESFORCE | Technology | 4.1% | $252.3m | 7,881,486 | -9% | reduced |
| 9 | AMERICA MOVIL SAB DE CV SPON | 4.1% | $251.9m | 8,129,275 | -10% | reduced | |
| 10 | AVGO BROADCOM CORP | Technology | 3.9% | $242.7m | 14,304,562 | -29% | reduced |
| 11 | QCOM QUALCOMM INC | Technology | 3.9% | $242.3m | 6,762,210 | – | new |
| 12 | E M C CORP MASS | 3.9% | $239.5m | 22,871,425 | -44% | reduced | |
| 13 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 3.6% | $224.1m | 37,795,577 | 296% | added |
| 14 | MONSANTO COMPANY | 3.6% | $223.5m | 3,176,500 | – | new | |
| 15 | CME CME GROUP INC | Financial Services | 3.6% | $223.3m | 1,072,925 | -10% | reduced |
| 16 | SYK STRYKER CORP | Healthcare | 3.3% | $207.3m | 5,189,745 | -10% | reduced |
| 17 | FMC TECHNOLOGIES INC | 3.3% | $205.7m | 8,631,843 | 7% | added | |
| 18 | IRON MTN INC | 2.4% | $148.5m | 6,006,411 | -10% | reduced | |
| 19 | MCO MOODYS CORP | Financial Services | 2.2% | $139.7m | 6,951,665 | -44% | reduced |
| 20 | MINDRAY MEDICAL INTL LTD SPON | 2.2% | $136.3m | 7,572,347 | 434% | added | |
| 21 | ABRAXIS BIOSCIENCE INC NEW | 1.2% | $73.5m | 1,114,414 | -11% | reduced | |
| 22 | ISHARES TR RUSSELL1000GRW | 0.3% | $19.4m | 524,547 | 1808% | added | |
| 23 | NUVASIVE INC | 0.2% | $9.5m | 275,500 | -7% | reduced | |
| 24 | CELG CELGENE CORP | 0.1% | $4.9m | 88,720 | -8% | reduced | |
| 25 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 0.1% | $4.8m | 269,400 | 22% | added |
| 26 | SEQUENOM INC | 0.1% | $3.1m | 158,300 | -12% | reduced | |
| 27 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.0% | $2.8m | 114,700 | -20% | reduced |
| 28 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 0.0% | $2.8m | 92,600 | -43% | reduced |
| 29 | HANSEN MEDICAL INC | 0.0% | $2.6m | 360,326 | 4% | added | |
| 30 | GILD GILEAD SCIENCES INC | Healthcare | 0.0% | $2.6m | 50,700 | – | new |
| 31 | ST JUDE MEDICAL INC | 0.0% | $2.4m | 72,400 | – | new | |
| 32 | ALCON INC | 0.0% | $2.0m | 21,900 | – | new | |
| 33 | GTX INC DEL | 0.0% | $1.7m | 103,800 | -19% | reduced | |
| 34 | CSCO CISCO SYS INC | Technology | 0.0% | $1.5m | 91,900 | -13% | reduced |
| 35 | MEDAREX INC | 0.0% | $1.3m | 229,400 | 2% | added | |
| 36 | ULT RUSSELL 1000 GROWTH P | 0.0% | $1.2m | 55,225 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.